| related words |
| toxicology |
| biosensor |
| clia |
| twice |
| takeda |
| zileuton |
| diligent |
| nonclinical |
| scotland |
| volunteer |
| avalonrx |
| telaprevir |
| viaject |
| fabre |
| pierre |
| ceplene |
| polyheme |
| stimuvax |
| biopharmaceuticals |
| levulan |
|
| related documents |
| 1036968--2/7/2007--VAXGEN_INC |
| 914475--2/9/2007--NEUROCRINE_BIOSCIENCES_INC |
| 1066833--3/30/2007--DOV_PHARMACEUTICAL_INC |
| 1066833--3/15/2006--DOV_PHARMACEUTICAL_INC |
| 908440--5/15/2006--MANUGISTICS_GROUP_INC |
| 914475--2/8/2010--NEUROCRINE_BIOSCIENCES_INC |
| 1118361--3/15/2007--RENOVIS_INC |
| 1003201--4/29/2009--MUNICIPAL_MORTGAGE_&_EQUITY_LLC |
| 1036968--5/31/2007--VAXGEN_INC |
| 914475--2/4/2009--NEUROCRINE_BIOSCIENCES_INC |
| 895051--3/13/2009--ENTREMED_INC |
| 1275101--3/26/2009--BANK_OF_THE_JAMES_FINANCIAL_GROUP_INC |
| 1036968--8/30/2007--VAXGEN_INC |
| 914475--2/11/2008--NEUROCRINE_BIOSCIENCES_INC |
| 1118361--3/17/2008--RENOVIS_INC |
| 1118361--3/14/2006--RENOVIS_INC |
|
| related topics |
| {product, candidate, development} |
| {financial, litigation, operation} |
| {investment, property, distribution} |
| {regulation, government, change} |
| {personnel, key, retain} |
| {customer, product, revenue} |
| {property, intellectual, protect} |
| {cost, regulation, environmental} |
| {operation, international, foreign} |
| {loan, real, estate} |
| {stock, price, operating} |
| {product, liability, claim} |
| {tax, income, asset} |
| {interest, director, officer} |
| {competitive, industry, competition} |
| {acquisition, growth, future} |
| {system, service, information} |
| {cost, operation, labor} |
| {loss, insurance, financial} |
| {regulation, change, law} |
|